Topic Editors


Challenges and Future Prospects of Antibacterial Therapy, 2nd Edition
Topic Information
Dear Colleagues,
Antibiotic resistance has become one of the most pressing global health issues. The increase in multidrug-resistant (MDR) pathogens has resulted in higher rates of death and illness due to unsuccessful treatments, placing a significant strain on healthcare systems around the world. A key factor in this crisis is the improper and excessive use of antibiotics—not only in medical settings but also in non-medical fields such as agriculture and food production—which has hastened the development and dissemination of resistance. Although there is an urgent demand, creating new and effective treatments against MDR bacteria remains a challenging and ongoing task. Biofilms are microbial communities that adhere to surfaces and resist antibiotics, contributing to chronic infections. Targeting biofilm formation is vital for combating MDR pathogens and improving treatment outcomes. This topic aims to collect pioneering research and thorough reviews that focus on the latest progress in developing novel, biocompatible antimicrobial agents and strategies aimed at counteracting emerging MDR pathogens and biofilm formation. Areas of interest include, but are not limited to, the design, synthesis, and production of new antimicrobial materials and platforms; their biocompatibility assessment; and the evaluation of their therapeutic uses.
Prof. Dr. Kwang-sun Kim
Dr. Zehra Edis
Topic Editors
Keywords
- antibiotic resistance
- synergistic antibiotics
- nanoantibiotics
- endolysins/bacteriocins
- outermembrane vesicles
- photothermal therapy
- photodynamic therapy
- ROS-based antimicrobial therapy
- antibiofilm agents
- biocompatibility
- drug delivery system
Participating Journals
Journal Name | Impact Factor | CiteScore | Launched Year | First Decision (median) | APC | |
---|---|---|---|---|---|---|
![]()
Antibiotics
|
4.6 | 8.7 | 2012 | 15 Days | CHF 2900 | Submit |
![]()
International Journal of Molecular Sciences
|
4.9 | 9.0 | 2000 | 20.5 Days | CHF 2900 | Submit |
![]()
Microbiology Research
|
2.2 | 2.8 | 2010 | 20.7 Days | CHF 1600 | Submit |
![]()
Pharmaceuticals
|
4.8 | 7.7 | 2004 | 14 Days | CHF 2900 | Submit |
![]()
Pharmaceutics
|
5.5 | 10.0 | 2009 | 14.9 Days | CHF 2900 | Submit |
![]()
Nanomaterials
|
4.3 | 9.2 | 2010 | 15.4 Days | CHF 2400 | Submit |
![]()
Microorganisms
|
4.2 | 7.7 | 2013 | 15.2 Days | CHF 2700 | Submit |
Preprints.org is a multidisciplinary platform offering a preprint service designed to facilitate the early sharing of your research. It supports and empowers your research journey from the very beginning.
MDPI Topics is collaborating with Preprints.org and has established a direct connection between MDPI journals and the platform. Authors are encouraged to take advantage of this opportunity by posting their preprints at Preprints.org prior to publication:
- Share your research immediately: disseminate your ideas prior to publication and establish priority for your work.
- Safeguard your intellectual contribution: Protect your ideas with a time-stamped preprint that serves as proof of your research timeline.
- Boost visibility and impact: Increase the reach and influence of your research by making it accessible to a global audience.
- Gain early feedback: Receive valuable input and insights from peers before submitting to a journal.
- Ensure broad indexing: Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.
Related Topic
- Challenges and Future Prospects of Antibacterial Therapy (13 articles)